The Promise of 3D Biomaterial Bioprinting for Wound-Healing and Skin Tissue Restoration
Syed MB., Ahmed TAE., Hincke MT.
Narrative Review, published in Life (Basel) (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Life (Basel) (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 42195275
- PMCID
- PMC13208223
- DOI
- 10.3390/life16050718
Abstract (original English)
Wound-healing and skin regeneration are the focus of intensive research, driven by a rapidly expanding global market and the growing clinical demand for more effective interventions engineered to actively direct and enhance tissue regeneration. Recent advances in biomaterial engineering and 3D bioprinting have accelerated the development of highly customized, functional constructs mimicking native tissue. Together, these innovations are reshaping therapeutic strategies and expanding the translational potential of next-generation skin substitutes. This review presents an overview of the evolution of material printing technologies and the different categories of 3D bioprinting techniques and processing methods, followed by an evaluation of the properties of natural biomaterials as bioinks for skin wound-healing and their application in skin tissue engineering. Moreover, we provide a comprehensive global market analysis, with consideration of costs, benefits, and a SWOT analysis to identify the full potential of this technology for the development of novel skin wound-healing products. Recommendations and future perspectives are provided to guide researchers, clinicians, and industry partners on the current state and potential of adopting 3D bioprinting with natural biomaterials for effective wound-healing therapies.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.